Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does temsirolimus have a role in recurrent glioblastoma multiforme?

Nature Clinical Practice Oncology volume 3, pages 70–71 (2006)Cite this article

boxed-textGalanis E et al. (2005) Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study. J Clin Oncol 23: 5294–5304

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Chang SM et al. (2004) Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugs. Invest New Drugs 22: 427–435

    Article  CAS  Google Scholar 

  2. Chang SM et al. (2005) Phase II study of CCI-779 in patients with recurrent glioblastoma multiforme. Invest New Drugs 23: 357–361

    Article  CAS  Google Scholar 

  3. Macdonald DR et al. (1990) Response criteria for phase II studies of supratentorial malignant glioma. J Clin Oncol 8: 1277–1280

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Petra Roberts, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Professor and Lai Wan Kan Endowed Chair of Neurological Surgery and Director of the Division of Neuro-Oncology at the University of California, San Francisco (UCSF), San Francisco, CA, USA

    Susan M Chang

Authors
  1. Susan M Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susan M Chang.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Chang, S. Does temsirolimus have a role in recurrent glioblastoma multiforme?. Nat Rev Clin Oncol 3, 70–71 (2006). https://doi.org/10.1038/ncponc0424

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncponc0424

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing